KVCI Acquires Bioanalytical Lab Business from ZeeCRO Inc.
LEAWOOD, Kan.--(BUSINESS WIRE)--Kansas Venture Capital, Inc. (KVCI) has acquired the former AAIPharma bioanalytical division from ZeeCRO Inc. With its 30-year track record of developing entrepreneurial companies, KVCI will grow the bioanalytical business through organic and acquisition strategies to provide best-in-class analytical services for both the pharmaceutical and life sciences sectors.